Leadless Cardiac Pacemakers – The Future is Here!

Release Date: April 17, 2017
Expiration Date: April 16, 2020

Speaker

Judith Mackall, MD
Director, Clinical Cardiac Electrophysiology Fellowship Program
Irving and Virginia Spitz Master Clinician in Cardiology
Harrington Heart & Vascular Institute
University Hospitals
Associate Professor of Medicine, Case Western Reserve University

Dr. Mackall receives clinical research and fellowship support from and/or is a consultant for Boston Scientific, Medtronic, St. Jude Medical, Sorin and Biosense Webster, and the CME Program has determined there is no conflict of interest. 

Target Audience

This continuing medical education activity is intended for physicians, surgeons and other members of the health care team. Most presentations will benefit primary care physicians in clinical practice. Office managers and administrators may also benefit from awareness and discussion of clinical initiatives and quality management issues. 

Media

Recorded slides and audio presentation. Resource materials may include downloads of videos, print materials, slides or web pages.

Learning Objectives

After participating in this activity participants will be able to:

  1. Recognize the indications for implantation of permanent cardiac pacemakers
  2. Describe the differences in technology between transvenous pacemakers and leadless cardiac pacemakers
  3. Discuss the early clinical trial results of leadless cardiac pacemakers

Accreditation Statement

 

Case Western Reserve University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Case Western Reserve University School of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Planning Committee

Sri Krishna Madan Mohan, MD, Activity Director
Chief Quality Officer
UH Harrington Heart & Vascular Institute
Assistant Professor of Medicine
Case Western Reserve University School of Medicine
Dr. Mohan reports no financial relationship with a commercial interest relevant to this activity.

Trevor Jenkins, MD
Division of Cardiovascular Medicine
UH Cleveland Medical Center
Assistant Professor of Medicine
Case Western Reserve University School of Medicine
Dr. Jenkins reports no financial relationship with a commercial interest relevant to this activity.

Disclosure Statement

The policy of Case Western Reserve University School of Medicine CME Program (CWRU CME) requires that the Activity Director, planning committee members and all activity faculty (that is, anyone in a position to control the content of the educational activity) disclose to the activity participants all relevant financial relationships with commercial interests. Where disclosures have been made, conflicts of interest, real or apparent, must be resolved. Disclosure will be made to activity participants prior to the commencement of the activity. CWRU CME also requires that faculty make clinical recommendations based on the best available scientific evidence and that faculty identify any discussion of “off-label” or investigational use of pharmaceutical products or medical devices.

Instructions

To receive a statement of credit for up to 1.0 AMA PRA Category 1 CreditTMyou must:

  1. Review and reflect on the full content of the recorded session.
  2. Successfully complete the post-test. A score of 75% is required for passage.
  3. Complete the evaluation.

Your credits will be recorded by the CWRU CME Program and made a part of your cumulative transcript.

Estimated Time to Complete this Educational Activity

Including review of any resource material and completion of the post-test, this activity is expected to take 1 hour to complete.

Fee

There is no fee for this program.

To contact the CME Provider: Email CWRU CME at medcme@case.edu

Medical Disclaimer

Medicine is an ever-changing science. As new research and clinical experience broaden our knowledge, changes in treatment and drug therapy are required. The authors have checked with sources believed to be reliable in their efforts to provide information that is complete and generally in accord with the standards accepted at the time of publication.

Although every effort is made to ensure that this material is accurate and up-to-date, it is provided for the convenience of the user and should not be considered definitive.  Since medicine is an ever-changing science, neither the authors nor Case Western Reserve School of Medicine nor any other party who has been involved in the preparation or publication of this work warrants that the information contained herein is in every respect accurate or complete, and they are not responsible for any errors or omissions or for the results obtained from the use of such information. 

Readers are encouraged to confirm the information contained herein with other sources.  This information should not be construed as personal medical advice and is not intended to replace medical advice offered by physicians. Case Western Reserve University School of Medicine will not be liable for any direct, indirect, consequential, special, exemplary, or other damages arising therefrom.

Resources

Epstein, Andrew E., et al. "2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities." Circulation 127.3 (2013): e283-e352. 

Reddy, Vivek Y., et al. "Percutaneous implantation of an entirely intracardiac leadless pacemaker." New England Journal of Medicine 373.12 (2015): 1125-1135.

Presenter

Judith Mackall, MD

Judith Mackall, MD Chief Community Officer – Eastern Region
UH Harrington Heart & Vascular Institute
Spitz Master Clinician
Director, Electrophysiology Fellowship Program
UH Cleveland Medical Center
Associate Professor of Medicine
Case Western Reserve University School of Medicine
View Full Profile